MARKET

OPK

OPK

OPKO Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.560
-0.030
-1.89%
After Hours: 1.560 0 0.00% 19:51 01/17 EST
OPEN
1.610
PREV CLOSE
1.590
HIGH
1.630
LOW
1.560
VOLUME
3.65M
TURNOVER
--
52 WEEK HIGH
3.870
52 WEEK LOW
1.330
MARKET CAP
1.04B
P/E (TTM)
-3.2629
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OPK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OPK News

  • Weekly CEO Buys Highlight
  • GuruFocus.com.4d ago
  • OPKO Health: The Fallen Bird
  • Seeking Alpha - Article.01/08 18:31
  • Weekly CEO Buys Highlight
  • GuruFocus.com.01/06 15:40
  • Insider Weekends: A Lost Decade Of Insider Buying By Dr. Frost
  • Seeking Alpha - Article.01/06 14:04

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About OPK

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
More

Webull offers Opko Health Inc. (OPK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.